Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

Yes. There was something odd about the placebo rate in that arm of the trial. It had superior results even compared to GC4419 which received BTD. It was about 30% lower than in the other two trials.

SOM in subjects with cisplatin Q1W schedule in IPIX trial.
Brilacidin: 7 / 13 or 53.8 %
Placebo: 5 / 11 or 45.5 %
Note: surprisingly low SOM rate for placebo.

Galera got BTD for GC4419 based on efficacy also in cisplatin Q1W group:
GC4419: 22 / 46 or 47.8 %
placebo: 31 / 46 or 64.9 %

If we can just find out what those placebo pills were packed with we will have OM licked!